top of page
NOVEL DRUGS
Novel drugs in cancer refer to new and innovative medications that are being developed to treat cancer. These drugs are typically designed to target specific molecular pathways or cellular mechanisms that are involved in the growth and spread of cancer cells.
Rucaven (Rucaparib) is a novel drug used for the treatment of ovarian cancer. It is a type of PARP inhibitor, which works by blocking the activity of an enzyme called poly (ADP-ribose) polymerase (PARP), which helps repair damaged DNA in cells. By blocking PARP, Rucaparib can help prevent cancer cells from repairing their DNA, which can lead to their death. Know more.
bottom of page